202 related articles for article (PubMed ID: 21738054)
1. Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment.
Wu VC; Kuo CC; Wang SM; Liu KL; Huang KH; Lin YH; Chu TS; Chang HW; Lin CY; Tsai CT; Lin LY; Chueh SC; Kao TW; Chen YM; Chiang WC; Tsai TJ; Ho YL; Lin SL; Wang WJ; Wu KD;
J Hypertens; 2011 Sep; 29(9):1778-86. PubMed ID: 21738054
[TBL] [Abstract][Full Text] [Related]
2. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma.
; Wu VC; Chueh SC; Chang HW; Lin LY; Liu KL; Lin YH; Ho YL; Lin WC; Wang SM; Huang KH; Hung KY; Kao TW; Lin SL; Yen RF; Chen YM; Hsieh BS; Wu KD
Am J Kidney Dis; 2009 Oct; 54(4):665-73. PubMed ID: 19628318
[TBL] [Abstract][Full Text] [Related]
3. Relative glomerular hyperfiltration in primary aldosteronism.
Ribstein J; Du Cailar G; Fesler P; Mimran A
J Am Soc Nephrol; 2005 May; 16(5):1320-5. PubMed ID: 15800124
[TBL] [Abstract][Full Text] [Related]
4. Relationships of plasma renin levels with renal function in patients with primary aldosteronism.
Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
Clin J Am Soc Nephrol; 2007 Jul; 2(4):722-31. PubMed ID: 17699488
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
[TBL] [Abstract][Full Text] [Related]
6. Kidney impairment in primary aldosteronism.
Wu VC; Yang SY; Lin JW; Cheng BW; Kuo CC; Tsai CT; Chu TS; Huang KH; Wang SM; Lin YH; Chiang CK; Chang HW; Lin CY; Lin LY; Chiu JS; Hu FC; Chueh SC; Ho YL; Liu KL; Lin SL; Yen RF; Wu KD;
Clin Chim Acta; 2011 Jul; 412(15-16):1319-25. PubMed ID: 21345337
[TBL] [Abstract][Full Text] [Related]
7. Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.
Novello M; Catena C; Nadalini E; Colussi GL; Baroselli S; Chiuch A; Lapenna R; Bazzocchi M; Sechi LA
J Hypertens; 2007 Jul; 25(7):1443-50. PubMed ID: 17563567
[TBL] [Abstract][Full Text] [Related]
8. Long-term renal outcomes in patients with primary aldosteronism.
Sechi LA; Novello M; Lapenna R; Baroselli S; Nadalini E; Colussi GL; Catena C
JAMA; 2006 Jun; 295(22):2638-45. PubMed ID: 16772627
[TBL] [Abstract][Full Text] [Related]
9. Comparison of renal function markers in Kuwaiti patients with sickle cell disease.
Marouf R; Mojiminiyi O; Abdella N; Kortom M; Al Wazzan H
J Clin Pathol; 2006 Apr; 59(4):345-51. PubMed ID: 16567469
[TBL] [Abstract][Full Text] [Related]
10. Intrarenal hemodynamics in primary aldosteronism before and after treatment.
Sechi LA; Di Fabio A; Bazzocchi M; Uzzau A; Catena C
J Clin Endocrinol Metab; 2009 Apr; 94(4):1191-7. PubMed ID: 19141581
[TBL] [Abstract][Full Text] [Related]
11. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
[TBL] [Abstract][Full Text] [Related]
12. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
[TBL] [Abstract][Full Text] [Related]
13. Primary aldosteronism: A common and curable form of hypertension.
Young WF
Cardiol Rev; 1999; 7(4):207-14. PubMed ID: 10423672
[TBL] [Abstract][Full Text] [Related]
14. Glomerular filtration rate estimation in renal transplant patients based on serum cystatin-C levels: comparison with other markers of glomerular filtration rate.
Visvardis G; Griveas I; Zilidou R; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Ginikopoulou E; Meimaridou D; Pavlitou A; Sakellariou G
Transplant Proc; 2004; 36(6):1757-9. PubMed ID: 15350470
[TBL] [Abstract][Full Text] [Related]
15. [Cystatin C as estimator of glomerular filtration rate in patients with advanced chronic renal disease].
Martín MV; Barroso S; Herráez O; de Sande F; Caravaca F
Nefrologia; 2006; 26(4):433-8. PubMed ID: 17058854
[TBL] [Abstract][Full Text] [Related]
16. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.
Sato H; Kuroda T; Tanabe N; Ajiro J; Wada Y; Murakami S; Sakatsume M; Nakano M; Gejyo F
Scand J Rheumatol; 2010; 39(1):33-7. PubMed ID: 20132068
[TBL] [Abstract][Full Text] [Related]
17. Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes.
Rigalleau V; Beauvieux MC; Le Moigne F; Lasseur C; Chauveau P; Raffaitin C; Perlemoine C; Barthe N; Combe C; Gin H
Diabetes Metab; 2008 Nov; 34(5):482-9. PubMed ID: 18703370
[TBL] [Abstract][Full Text] [Related]
18. Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy.
Nakano Y; Yoshimoto T; Fukuda T; Murakami M; Bouchi R; Minami I; Hashimoto K; Fujii Y; Kihara K; Ogawa Y
Intern Med; 2018 Sep; 57(17):2459-2466. PubMed ID: 29709927
[TBL] [Abstract][Full Text] [Related]
19. QT interval in patients with primary aldosteronism and low-renin essential hypertension.
Maule S; Mulatero P; Milan A; Leotta G; Caserta M; Bertello C; Rabbia F; Veglio F
J Hypertens; 2006 Dec; 24(12):2459-64. PubMed ID: 17082730
[TBL] [Abstract][Full Text] [Related]
20. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
